Akero Therapeutics Inc buy UBS Group AG
Start price
12.10.23
/
50%
€14.00
Target price
12.10.24
€37.01
Performance (%)
92.86%
End price
13.10.24
€27.00
Summary
This prediction ended on 13.10.24 with a price of €27.00. With a performance of 92.86% the BUY prediction by UBS_Group_AG was a big success. UBS_Group_AG has a follow-up prediction for Akero Therapeutics Inc where he still thinks Akero Therapeutics Inc is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akero Therapeutics Inc | 0.278% | 0.278% | 67.391% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by UBS_Group_AG for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its price target lowered by analysts at UBS Group AG from $83.00 to $39.00. They now have a "buy" rating on the stock.
Ratings data for AKRO provided by MarketBeat
In the thread Trading Akero Therapeutics Inc
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€52.08
31.01.25
31.01.25
€105.08
31.01.26
31.01.26
-9.81%
08.12.25
08.12.25
Stopped prediction by UBS_Group_AG for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€26.60
05.03.24
05.03.24
€38.62
05.03.25
05.03.25
54.62%
06.03.25
06.03.25
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€46.20
28.08.23
28.08.23
€76.75
28.08.24
28.08.24
-48.68%
29.08.24
29.08.24